Peripheral nerve myelin protein 22: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Howard C. Berkowitz
(New page: {{subpages}} '''Peripheral nerve myelin protein 22 (PMP22)''' is clinically significant in several genetic peripheral neuropathies. In [[Charcot-Marie-Tooth disea...)
 
imported>Howard C. Berkowitz
No edit summary
Line 1: Line 1:
{{subpages}}
{{subpages}}
'''Peripheral nerve myelin protein 22 (PMP22)''' is clinically significant in several genetic [[peripheral neuropathy|peripheral neuropathies]]. In [[Charcot-Marie-Tooth disease]], the PMP22 gene is duplicated; in [[hereditary neuropathy with sensitivity to pressure palsies]] (HBPP), the gene is omitted.
'''Peripheral nerve myelin protein 22 (PMP22)''' is clinically significant in several genetic [[peripheral neuropathy|peripheral neuropathies]]. There are several subclasses of [[Charcot-Marie-Tooth disease]] (CMT), with loci mapping to chromosome 17 (CMT1A), chromosome 1 (CMT1B) and to another unknown autosome (CMT1C). In  [[hereditary neuropathy with sensitivity to pressure palsies]] (HNPP),autosomal dominant disorder that results in a recurrent, episodic demyelinating neuropathy. HNPP is associated with a 1.5-Mb deletion in chromosome 17p11.2-12 and results from reduced expression of the PMP22 gene. CMT1A and HNPP are reciprocal duplication/deletion syndromes originating from unequal crossover during germ cell meiosis.<ref name=Keller1999>{{citation
| journal = Brain Pathol
| date = 1999 Apr
| volume = 9 | pages = 327-41
| title = Inherited neuropathies: from gene to disease.
| author = Keller MP, Chance PF
| url = http://www.ncbi.nlm.nih.gov/pubmed/10219749?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_SingleItemSupl.Pubmed_Discovery_RA&linkpos=4&log$=relatedreviews&logdbfrom=pubmed
}}</ref> 


In [[hereditary motor and sensory neuropathy type 1a]] (HMSN1a), the level of anti-PMP22 antibody indicated a trend toward the progression of disease. <ref>{{citation
In [[hereditary motor and sensory neuropathy type 1a]] (HMSN1a), the level of anti-PMP22 antibody indicated a trend toward the progression of disease. <ref>{{citation
Line 8: Line 15:
  | pages = 230-235  
  | pages = 230-235  
  | doi=10.1136/jnnp.72.2.230
  | doi=10.1136/jnnp.72.2.230
| url = http://jnnp.bmj.com/content/72/2/230.full
  | title = Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN1a)
  | title = Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN1a)
  | author = Gabriel CM, Gregson NA, Wood NW, Hughes RAC}}</ref>
  | author = Gabriel CM, Gregson NA, Wood NW, Hughes RAC}}</ref>
An inflammatory polyneuropathy may become superimposed on patients with CMT. <ref>{{citation
| journal = Brain
| date = 2004 Jan (ePub 7 November 2003)
| volume=127(Pt 1)
| pages = 193-202
| title = Coexistent hereditary and inflammatory neuropathy<r
| author = Ginsberg L, Malik O, Kenton AR, Sharp D, Muddle JR, Davis MB, Winer JB, Orrell RW, King RH
| url = http://www.ncbi.nlm.nih.gov/pubmed/14607795?dopt=Abstract}}</ref>


==References==
==References==
{{reflist}}
{{reflist|2}}

Revision as of 14:37, 31 January 2010

This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

Peripheral nerve myelin protein 22 (PMP22) is clinically significant in several genetic peripheral neuropathies. There are several subclasses of Charcot-Marie-Tooth disease (CMT), with loci mapping to chromosome 17 (CMT1A), chromosome 1 (CMT1B) and to another unknown autosome (CMT1C). In hereditary neuropathy with sensitivity to pressure palsies (HNPP),autosomal dominant disorder that results in a recurrent, episodic demyelinating neuropathy. HNPP is associated with a 1.5-Mb deletion in chromosome 17p11.2-12 and results from reduced expression of the PMP22 gene. CMT1A and HNPP are reciprocal duplication/deletion syndromes originating from unequal crossover during germ cell meiosis.[1]

In hereditary motor and sensory neuropathy type 1a (HMSN1a), the level of anti-PMP22 antibody indicated a trend toward the progression of disease. [2]

An inflammatory polyneuropathy may become superimposed on patients with CMT. [3]

References

  1. Keller MP, Chance PF (1999 Apr), "Inherited neuropathies: from gene to disease.", Brain Pathol 9: 327-41
  2. Gabriel CM, Gregson NA, Wood NW, Hughes RAC (2002), "Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN1a)", J Neurol Neurosurg Psychiatry 72: 230-235, DOI:10.1136/jnnp.72.2.230
  3. Ginsberg L, Malik O, Kenton AR, Sharp D, Muddle JR, Davis MB, Winer JB, Orrell RW, King RH (2004 Jan (ePub 7 November 2003)), "Coexistent hereditary and inflammatory neuropathy<r", Brain 127(Pt 1): 193-202